The Covid omicron variant significantly reduces antibodies generated by Pfizer and BioNTech’s vaccine, according to a small preliminary study released Tuesday.
All rights reserved by www.dividendstocksreport.net
Get the daily email about stock.
Please Enter Your Email Address:
By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!